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Abstract
Lissencephaly is a brain developmental disorder characterized by disorganization of the cortical regions resulting from
defects in neuronal migration. Recent evidence has implicated the human LIS-1 gene in Miller^Dieker lissencephaly and
isolated lissencephaly sequence. LIS-1 is homologous to the fungal genes NudF and PAC1, which are involved in cytoplasmic
dynein mediated nuclear transport, but it is also almost identical to a subunit of PAF acetylhydrolase, an enzyme which
inactivates the lipid mediator platelet activating factor. Recent evidence from our laboratory has revealed that cytoplasmic
dynein coimmunoprecipitates with LIS-1 in bovine brain cytosol, supporting a role in the dynein pathway in vertebrates.
Overexpression of LIS-1 interferes with cell division, with noteworthy effects on chromosome attachment to the mitotic
spindle and on the interaction of astral microtubules with the cell cortex. Other aspects of dynein function, such as the
organization of the Golgi apparatus, are not affected. Together, these results suggest a role for LIS-1 in cytoplasmic dynein
functions involving microtubule plus-ends. Furthermore, they suggest that mutations in LIS-1 may produce a lissencephalic
phenotype either by interfering with the movement of neuronal nuclei within extending processes, or by interference with the
division cycle of neuronal progenitor cells in the ventricular and subventricular zones of the developing nervous
system. ß 2000 Elsevier Science B.V. All rights reserved.
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1. Introduction
Both kinesin and cytoplasmic dynein were identi-
¢ed initially in nervous tissue, where, based on their
di¡erent direction of force production, they were
proposed to account for anterograde and retrograde
axonal transport, respectively [1,2]. It has become
clear that higher eukaryotes express multiple forms
of kinesin and dynein which are responsible for a
great diversity of motile phenomena in the cell. The
distribution of duties among the dyneins is very dif-
ferent from that for the kinesins, however. In the
latter case, each of a substantial number of kinesin-
related genes within a given organism has a relatively
limited function. In contrast, almost all of the dy-
neins function within the ciliary or £agellar axoneme.
A single major form of cytoplasmic dynein has been
implicated in a wide range of functions, including not
only retrograde axonal transport, but also prometa-
phase chromosome movement, mitotic spindle pole
organization, spindle orientation, nuclear migration,
Golgi, lysosome, and endosome distribution, micro-
tubule organization and reorganization, and trans-
port of certain viruses to the nucleus [3,4]. A less
prominent form of cytoplasmic dynein, which is ex-
pressed transiently in the nervous system and in oth-
er tissues, has been implicated in a more discrete
function, intra£agellar protein transport [5].
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Given the physiological importance of the major
form of cytoplasmic dynein, it is not surprising to
¢nd evidence that defects in its regulation may have
serious developmental consequences. Recent work has
implicated the human LIS-1 gene, which is responsible
for a form of the brain developmental disease lissen-
cephaly, in cytoplasmic dynein function. However, the
relationship between LIS-1 and dynein is obscure, and
understanding whether and how LIS-1 and dynein
interact is complicated by the potential involvement
of LIS-1 in other cellular processes.
Here we review current knowledge about LIS-1
and related genes in other organisms, and explore
how LIS-1 and cytoplasmic dynein functions may
overlap.
2. Structure and function of cytoplasmic dynein and
dynactin
Cytoplasmic dynein is a 1.2 MDa complex which
consists of at least four di¡erent classes of subunit:
heavy (532 kDa), intermediate (74 kDa), light inter-
mediate (55, 57 kDa), and light chains (8^14 kDa).
The heavy chains contain the dynein motor domain,
itself a large globular structure with four ATPase
sites and an extended ‘stalk’ which interacts at its
tip with microtubules [6]. Several of the other cyto-
plasmic dynein subunits have been implicated in sub-
cellular targeting. The intermediate chains reside at
the base of the motor protein [7] and interact with
another multisubunit complex, dynactin [8,9]. Dis-
ruption of dynactin by overexpression of one of its
subunits, dynamitin, releases cytoplasmic dynein
from mitotic kinetochores and interferes with a
wide range of functions [10]. These results suggest
that dynactin controls and mediates the interaction
of cytoplasmic dynein with a variety of subcellular
structures. Recent evidence suggests that the light
intermediate chains may also be involved in subcel-
lular targeting. Rat LIC1 has been found to interact
directly with pericentrin, a polypeptide reported to
require cytoplasmic dynein for its assembly onto cen-
trosomes [11]. A cytoplasmic dynein light chain has
also been reported to bind to the cytoplasmic tail of
rhodopsin, potentially mediating the association of
rod outer segment precursors with the motor protein
[12].
3. Role of the LIS-1 gene in lissencephaly
The lissencephaly (from the Greek: smooth brain)
syndromes are a family of diseases which involve
incomplete development of the human brain [13]
characterized by extensive disorganization of cortical
neurons. This defect is thought to arise from an ap-
parent failure in some aspect of neuronal cell body
migration during the early stage of brain develop-
ment. As a result of the extensive histological disor-
ganization, the convolutions characteristic of the
normal vertebrate brain surface are reduced in extent
and number, and all or portions of the brain appears
smooth. Lissencephaly occurs alone or, in the case of
Miller^Dieker syndrome, as one of several patholog-
ical features. Miller^Dieker syndrome and some
cases of isolated lissencephaly sequence have been
found to arise from mutations at the LIS-1 locus
in humans [14^16]. Point mutations and deletions
within the LIS-1 gene are su⁄cient to produce lis-
sencephaly, while larger deletions produce a range of
additional defects characteristic of Miller^Dieker
syndrome [17,18]. Deletions completely eliminating
one of the two LIS-1 alleles are dominant, indicating
that lissencephaly results from reduced gene dosage
[15]. Partial and conditional knockouts of the LIS-1
gene in mouse have been produced [19]. Homozy-
gous null mutants exhibited early embryonic post-
implantation lethality, indicating that LIS-1 function
is essential for embryonic development. Reduced
gene dosage produced a lissencephalic phenotype
similar to that observed in humans.
4. Relationship of LIS-1 to other genes
The sequence of the LIS-1 gene has implicated it in
two apparently distinct physiological pathways, one
involving platelet activating factor and the other cy-
toplasmic dynein.
4.1. Relationship of LIS-1 to platelet activating factor
metabolism
The human LIS-1 gene encodes a 45 kDa poly-
peptide [15] which is 99% identical in amino acid
sequence to a bovine polypeptide identi¢ed as a
subunit of PAF acetylhydrolase 1b. PAF acetyl-
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hydrolases serve to inactivate platelet activating fac-
tor, or PAF [20], a phospholipid messenger with a
wide range of physiological functions. PAF is well
known as a mediator of the in£ammatory response,
but it is produced in a variety of tissues, including
brain, and has been implicated in a variety of other
processes. PAF acetylhydrolase removes an acetate
group from the sn-2 position of platelet activating
factor, producing the biologically inactive lyso-PAF
(reviewed in [21^23]). Multiple forms of the enzyme
have been identi¢ed in both particulate and soluble
tissue fractions. Bovine brain cytosolic PAFAH 1b
has been puri¢ed and characterized extensively
[20,24,25]. The K-1 and K-2 subunits (29, 30 kDa)
have catalytic activity, while the 45 kDa L-subunit
(LIS-1) does not.
How the association of LIS-1 with PAFAH relates
to the e¡ects of LIS-1 mutations on brain develop-
ment is uncertain. Evidence to date has not revealed
a clear role for LIS-1 in PAFAH enzymatic regula-
tion [20]. Catalytic activity was apparently una¡ected
by chromatographic removal of LIS-1 using heparin^
Sepharose, and the speci¢c activity of recombinant
K-subunits was comparable to that of the holoen-
zyme [20]. Furthermore, another active isoform of
PAF acetylhydrolase (PAFAH 1a from liver) consists
of only the two catalytic subunits (Hattori et al.,
unpublished observations cited in [25]), indicating
that LIS-1 is not an obligate component of the en-
zyme. Finally, no orthologue of the catalytic subunit
is apparent in yeast, where, however, a LIS-1-related
protein is active (see below). Together these data
raise the possibility that LIS-1 is involved in some
other aspect of PAFAH regulation, or that, after all,
LIS-1 and PAFAH are not physiologically related
despite clear evidence for their stoichiometric cofrac-
tionation [20].
On the other hand, attempts to identify a role for
PAF in neurons have suggested an e¡ect on neuronal
di¡erentiation and motility [26,27]. In cerebellar
granule cell reaggregate cultures, PAF and a more
stable PAF agonist, mc-PAF, caused an immediate
and rapidly reversible inhibition of nuclear migration
within preexisting neurites [26]. This e¡ect could be
distinguished from a smaller inhibitory e¡ect on neu-
rite outgrowth and was blocked by PAF receptor
antagonists. In hippocampal neurons PAF induced
growth cone collapse, neurite retraction, and an in-
creased appearance of varicosities. Changes were ob-
served in the distribution and organization of micro-
tubules and actin ¢laments, which were postulated to
underlie the other cellular alterations [27].
4.2. Relationship of LIS-1 to cytoplasmic dynein
regulation
LIS-1-related genes in fungi have been implicated
in cytoplasmic dynein function, raising the possibility
that LIS-1 itself may function in the cytoplasmic dy-
nein pathway in vertebrates. Defects in the Aspergil-
lus nud and Neurospora ropy genes block nuclear
transport into and within hyphal processes [28^30].
Sequence analysis has revealed that several of these
genes encode cytoplasmic dynein and dynactin sub-
units, including a dynein heavy (nudA, ro-1 : [28,31]),
and light chain (nudG : [32]), and the dynactin sub-
units p150Glued , Arp1, and p62 (ro-2, -3, and -4, and
nudK : [28,33^35]). nudF encodes a 49 kDa polypep-
tide which shows 42% sequence identity (62% simi-
larity) to mammalian LIS-1 [31]. Homology is ob-
served throughout the length of the two sequences
(Fig. 1), suggesting that nudF may be a functional
Fig. 1. Dot plot comparison of LIS-1 (African green monkey:
N.E. Faulkner, R.B. Vallee, unpublished results) and nudF (As-
pergillus nidulans) [31]. Homology between the two polypeptide
sequences is observed throughout their length. Internal homol-
ogy between WD40 domains is also apparent (a.a. 125 to C-ter-
minus).
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homologue of LIS-1. One allele of the cytoplasmic
dynein heavy chain gene has been found to suppress
partially mutations in nudF [36], consistent with a
direct involvement of nudF in dynein function. Fur-
thermore, the phenotype of a nudA/nudFts double
mutant was no more severe than that of the individ-
ual mutants.
Defects in cytoplasmic dynein and dynactin in Sac-
charomyces cerevisiae a¡ect the orientation of the
dividing nucleus as it extends into the bud, resulting
in defects in chromosome segregation. This pheno-
type is produced by mutations in the cytoplasmic
dynein heavy chain [37,38] and the dynactin subunits
dynamitin [39], Arp1 [40,41] and p150Glued [42]. The
PAC mutants, identi¢ed on the basis of a genetic
interaction with the mitotic kinesin-related protein
cin8, were found to exhibit defects in nuclear orien-
tation and chromosome segregation comparable to
those observed in dynein and dynactin mutants.
Among the PAC genes are those encoding the cyto-
plasmic dynein heavy and intermediate chains, Arp1,
p150Glued , and dynamitin [43]. PAC1 [43], like nudF,
is related to LIS-1 throughout its length (33% iden-
tity, 47% similarity).
Based on the sequence relationship between LIS-1,
nudF, and PAC1, and the dynein-like phenotype ex-
hibited by mutant alleles of the fungal genes, it is
appealing to speculate that LIS-1 is also involved
in nuclear movement, which, in turn, could be in-
volved in at least some aspects of neuronal cell
body migration. The latter process is a general and
important phenomenon in brain and spinal cord de-
velopment (see, e.g., [44^46]). One well-documented
example is the cyclical movement of neuroepithelial
germinal cell nuclei toward and away from the ven-
tricular surface of the developing CNS [47]. Subse-
quent radial migration of di¡erentiating granule cells
and other neurons, as well as glial cells, is also well
documented [48^50]. Although clear evidence for nu-
clear transport within extending processes has been
observed [50], the relative contribution of this pro-
cess to other potential mechanisms for cell body
movement is not thoroughly understood. Thus, de-
fects in cytoplasmic dynein function might a¡ect
some, but not necessarily all, aspects of cell body
migration, and the potential impact on brain devel-
opment is therefore unknown.
Cytoplasmic dynein function might also a¡ect neu-
ronal cell body migration indirectly, for example
through e¡ects on mitotic progression, spindle orien-
tation, or other aspects of cell division. It is well
known that the timing of cell division in the ventric-
ular zone a¡ects the ultimate destination of neurons
in their subsequent journey through the cortical
layers of the brain [49,51]. Thus, LIS-1 could a¡ect
neuronal migration by a¡ecting any of a number of
roles attributed to dynein during mitosis. Dynein has
been implicated in chromosome capture based on the
rapid, poleward chromosome movements observed
during early prometaphase [52], the localization of
dynein and dynactin to the prometaphase kineto-
chore [10,53,54], and the e¡ects of dynamitin over-
expression, as noted above [10]. Inhibition of dynein
function by use of anti-intermediate chain antibodies
or excess dynamitin in both living cells and cell-free
systems has also been found to interfere with the
organization of spindle poles [11,55,56]. Finally, dy-
nein has been implicated in spindle orientation based
on the use of RNA interference techniques to inhibit
expression of dynamitin and p150Glued in early Cae-
norhabditis elegans embryos [57] and on the e¡ects of
dynamitin overexpression in cultured mammalian
cells [10,58].
Recent reports have identi¢ed a LIS-1 homologue
in Drosophila melanogaster. Investigation of the phe-
notype of LIS-1 mutant £ies revealed defects in nu-
clear positioning within oocytes and developing pho-
toreceptor cells [59] and in the proliferation of nurse
cells [60]. Mutations in the LIS-1 gene exhibited al-
lele-speci¢c suppression by a cytoplasmic dynein
heavy chain mutation, adding further support to a
role for LIS-1 in cytoplasmic dynein function.
5. Possible interaction of LIS-1 with cytoplasmic
dynein
Only limited existing information bears on the is-
sue of whether LIS-1 interacts physically with cyto-
plasmic dynein. LIS-1 has been found to colocalize
with microtubules by immuno£uorescence microsco-
py [61]. Whether this result supports a direct inter-
action with tubulin or dynein is uncertain, as motor
protein antigens typically exhibit very limited micro-
tubule colocalization. Dynactin can associate with
microtubules, although it is restricted to microtubule
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plus-ends [62]. Dynein in general was not observed to
associate with microtubules, but could be induced to
codistribute with dynactin to the plus-ends at re-
duced temperatures [62]. Recent analysis of the dis-
tribution of LIS-1 in Drosophila oocytes has revealed
a cortical rather than a microtubular distribution
[59].
LIS-1 was also reported to show partial cosedi-
mentation with microtubules and to inhibit microtu-
bule dynamic instability in vitro [61]. However, sed-
imentation analysis of Aspergillus cytosolic extracts
showed the nudF gene product to sediment at low s-
value, independent of the 20S cytoplasmic dynein
peak [31]. Cytoplasmic dynein has been observed
by our laboratory to coimmunoprecipitate with
LIS-1 [63]. Whether this result re£ects a direct or
indirect interaction remains to be determined. How-
ever, we note that LIS-1 shares noteworthy similar-
ities in secondary structure with the dynein inter-
mediate chains, as do nudF and PAC (Fig. 2). All
of these polypeptides have short N-terminal pre-
dicted coiled-coil regions, and contain six or seven
WD40 repeats, suggesting a common L-propeller
fold, located within the C-terminal half [64^66].
These data are consistent with a functional relation-
ship between the dynein intermediate chains and
LIS-1, nudF, and PAC1, although no signi¢cant pri-
mary sequence homology between the intermediate
chains and the LIS-1-related polypeptides is appar-
ent. Whether the secondary structural relationship
between the several polypeptides is fortuitous or re-
£ects a common association with the dynein complex
remains to be determined.
6. LIS-1 overexpression phenotype
As another test of the relationship between LIS-1
and cytoplasmic dynein, we have examined the ef-
fects of LIS-1 overexpression in cultured mammalian
cells [63,67]. This approach has proven valuable in
analyzing dynactin and cytoplasmic dynein function.
As noted above, overexpression of the dynamitin
subunit of dynactin causes a variety of phenotypic
e¡ects consistent with interference with cytoplasmic
dynein function [10,68]. These changes are correlated
with loss of the complex from mitotic kinetochores
and its physical disruption [10].
We have observed a pronounced increase in mi-
totic index in LIS-1 overexpressing COS-7 and
Fig. 2. Conservation of secondary structure. LIS-1 (human) is compared with nudF (Aspergillus nidulans), PAC1 (S. cerevisiae), and
cytoplasmic dynein intermediate chain IC-1 (rat). Predicted coiled-coil regions are indicated (C-C), as are WD repeats, which are
thought to form the L-propeller fold.
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MDCK cells. Dynamitin overexpression also produ-
ces an increased mitotic index (9^11% in COS-7
cells : [10]), but the e¡ect is more dramatic for
LIS-1 (mitotic index W33% in MDCK cells). LIS-1
overexpressing cells are also more uniformly distrib-
uted throughout mitosis, whereas dynamitin overex-
pressors accumulate in prometaphase.
LIS-1-overexpressing mitotic cells exhibited a vari-
ety of spindle defects. Approximately 10% of the
spindles were multipolar. This outcome could result
from a long mitotic delay, although fragmentation of
the spindle poles as we have seen in dynamitin-over-
expressing cells is also possible (C. Echeverri, R.B.
Vallee, unpublished observations). Numerous cells
exhibited unattached chromosomes. The possibility
that many of these chromosomes never succeed in
attaching to the spindle microtubules is strongly sug-
gested by the appearance of micronuclei in many
overexpressing cells observed during interphase. A
defect in kinetochore attachment is likely to contrib-
ute to the increased mitotic index, based on extensive
evidence for a kinetochore attachment checkpoint
(reviewed in [69]).
Another noteworthy defect observed in the LIS-1
overexpressing cells occurs during prometaphase. As-
tral microtubules, which are normally short and
straight, are hyperelongated in the LIS-1 overex-
pressing cells. Some are seen to curve back toward
the interior of the cell when they reach the cell cor-
tex. We also ¢nd the LIS-1 overexpressing cells to be
much £atter, broader, and irregularly shaped than
control prometaphase cells, an e¡ect which is re-
versed by nocodazole. Finally, many spindles in the
LIS-1 overexpressing cells are acentrically located.
All of these e¡ects may derive from the observed
changes in microtubule length and distribution. It
is possible, in turn, that the observed spindle misor-
ientation contributes to the high mitotic index in
LIS-1 overexpressors, by a¡ecting mitotic progres-
sion. This possibility is suggested by recent studies
in yeast [70] which have revealed a novel mitotic
checkpoint control mechanism in yeast which detects
misoriented mitotic nuclei and their enclosed spin-
dles. This checkpoint was found to be activated in
dynein and dynactin null mutants. Whether it func-
tions in the vertebrate cells involved in our studies
remains to be determined.
The overgrowth of mitotic microtubules observed
in the LIS-1 overexpressing cells seems likely to be
related to a defect in the interaction between micro-
tubules and the cell cortex as suggested by a variety
of data. First, this behavior is reminiscent of the
overgrowth of cytoplasmic microtubules in yeast cy-
toplasmic dynein, dynactin, and PAC1 mutants
[43,71]. The ends of the microtubules also fail to
interact with the cell cortex as they do in wild-type
cells, suggesting that dynein and dynactin normally
serve as cortical linkers. Dynein and dynactin have
been observed in the cortex of diving MDCK cells
[72] and in the plasma membrane of two-cell C. ele-
gans embryos during spindle reorientation [57], and
could serve a comparable role to that observed in
yeast.
As noted above, dynactin has been found associ-
ated with the distal (plus) ends of microtubules, po-
tentially representing another manifestation of inter-
action between microtubules, dynein, and the cell
cortex [62]. Dynactin colocalized with the p150Glued-
related protein CLIP-170 at the ends of a subset of
microtubules [62], which have been identi¢ed as those
in the process of growing [73]. Dynein was not nor-
mally detectable at the microtubule plus-ends, but
could be induced to codistribute with p150Glued at
these sites by exposure of cells to decreased temper-
ature prior to ¢xation [62]. Yet another microtubule
distal end associated protein, EB1 [74,75], which has
been reported to interact with the adenomatous poly-
posis coli (APC) protein and with dynactin [76], also
associates with the same microtubules (N.E. Faulk-
ner, R.B. Vallee, unpublished observations). Togeth-
er these data indicate that microtubules growing out-
ward toward the cell cortex carry a set of dynein- and
dynactin-related proteins which participate in micro-
tubule^cortical interactions.
To determine the relationship between LIS-1 and
the microtubule-associated dynein and dynactin in
vertebrate cells, we examined the distribution of the
latter proteins in LIS-1 overexpressing cells. The
p150Glued subunit of dynactin was clearly dissociated
from the microtubules. The association of EB1 with
the microtubules, in contrast, was una¡ected. The
latter result serves as a control to demonstrate that
the loss of p150Glued is not an indirect consequence of
microtubule stabilization, which has been reported to
eliminate both CLIP-170 and EB1 binding from mi-
crotubule plus-ends [73,74].
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In mitotic MDCK cells we ¢nd that LIS-1 over-
expression leads to substantial distortion of the nor-
mally symmetric distribution of cortical dynein and
dynactin using anti-intermediate chain, anti-dynami-
tin, and anti-p150Glued antibodies. Some dynein and
dynactin staining can still be observed at apparent
sites of interaction between microtubules and the
cell cortex. The extent to which these e¡ects re£ect
loss of dynein and dynactin from the cortex vs. dis-
organization of the staining pattern is not yet certain.
Together, our results support an e¡ect of LIS-1 at
microtubule plus-ends during both interphase and
mitosis.
7. Di¡erences from dynamitin overexpression
phenotype
Some of the e¡ects of LIS-1 and dynamitin over-
expression are comparable, but clear di¡erences are
also observed. Dynamitin, like LIS-1, causes a delay
in mitosis [10] but, as noted above, the increase in
mitotic index of dynamitin-overexpressing cells is not
as great as that observed with LIS-1. In addition,
dynamitin overexpressing cells accumulate in pro-
metaphase, whereas LIS-1 overexpressors are more
uniformly distributed throughout mitosis. Kineto-
chore attachment defects are not as obvious in dy-
namitin overexpressing cells, and micronuclei are not
generally observed. Spindle distortion and asymme-
try is, however, more pronounced. Dynamitin over-
expression has no e¡ect on the association of
p150Glued with the microtubule distal ends, although
the Arp1 subunits of the dynactin complex are lost
[62], consistent with dissociation of p150Glued and
Arp1 [10]. To compare other important aspects of
the two phenotypes, we examined prometaphase ki-
netochores in LIS-1 overexpressing cells for dynein
intermediate chain and p150Glued immunoreactivity.
In contrast to the e¡ects of dynamitin overexpres-
sion, both antigens were retained. This result sug-
gests that LIS-1 regulates dynein and dynactin func-
tion at the kinetochore, but not necessarily the
attachment to the two complexes to the kinetochore.
Fig. 3. Sites of potential LIS-1 action during mitosis. Mitotic spindle showing cytoplasmic dynein at plus-ends of microtubules inter-
acting with kinetochores and the cell cortex. Current evidence suggests these as possible sites at which dynein function may be regu-
lated by LIS-1.
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We also examined the e¡ects of LIS-1 overexpression
on Golgi organization using GFP-N-acetyl glucos-
amine transferase as a marker. In cells overexpress-
ing dynamitin or injected with anti-dynein inter-
mediate chain antibody, the Golgi apparatus is
dramatically dispersed as small stacks throughout
the cytoplasm [68]. No obvious change in Golgi dis-
tribution, however, was observed in LIS-1 overex-
pressing cells.
Together these results suggest that if LIS-1 is in-
deed involved in regulating cytoplasmic dynein,
some, but not all, aspects of dynein function are
a¡ected.
8. Mechanism of action of LIS-1
Our results suggest that LIS-1 may function at two
loci within the cell, the cortex and the prometaphase
kinetochore. We note that these sites share the im-
portant feature of interacting with the plus-ends of
microtubules (Fig. 3). This is more clearly established
for kinetochores, which can interact with the lateral
microtubules surface, but ultimately interact with the
very end [52]. The nature of the interaction between
dynein and the microtubule in these two states is
unknown. In particular, it is uncertain whether dy-
nein binds to di¡erent surfaces of the tubulin dimer
or instead, reaches around the end of the microtu-
bule to interact with the lateral surface. Although
this mode of interaction between dynein and micro-
tubule ends can be envisioned and seems feasible, the
steric constraints imposed by this arrangement may
require the activity of novel dynein regulators or
adaptors. Conceivably LIS-1 may function in this
capacity.
Whether the ends of microtubules interact with
components of the cell cortex is uncertain, although
images from dividing yeast cells suggest that such
an interaction does occur [71]. The nature of this
interaction is poorly understood, but it is conceivable
that it might involve similar constraints and have
common features with the microtubule-kinetochore
interaction. LIS-1 has been observed in the cortex
of Drosophila oocytes [59] where it could serve
to regulate the interaction between dynein and mi-
crotubule ends. Whether LIS-1 will be more gener-
ally found in the cortex and whether it is present at
Fig. 4. Potential roles of LIS-1 in brain development. Diagram shows neuronal progenitor cells in the ventricular zone of the verte-
brate central nervous system. Defects in neuronal distribution observed in lissencephalic brains could arise directly from changes in A,
cell cycle-dependent nuclear migration within dividing cells in the neuroepithelium (phases indicated at bottom); B, the cell division
cycle of neuronal progenitors; or C, nuclear migration within the extending processes of di¡erentiating neurons as they migrate out-
ward through the cortex. Modi¢ed after [77].
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the kinetochore remain important issues for future
study.
Our studies have not directly addressed how re-
duced LIS-1 gene dosage leads to lissencephaly.
However, they do suggest that, in addition to possi-
ble e¡ects on nuclear transport during neuronal mi-
gration, e¡ects on the division of neuronal progeni-
tor cells should also be considered (Fig. 4). The
results of our overexpression studies reveal accumu-
lation of cells in mitosis, and acentric localization of
the mitotic spindle. The latter result could re£ect a
role for LIS-1 in spindle orientation, which has been
clearly correlated with neuronal di¡erentiation and
migration (Fig. 4). Horizontal divisions give rise to
dissimilar progeny, the apical or lumenal one of
which continues to divide, whereas the basal or in-
ternal one of which migrates and di¡erentiates [77].
Thus, LIS-1 could a¡ect neuronal migration either
by a¡ecting the timing of mitosis, or the orientation
of the mitotic spindle.
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